AERIAL BIOPHARMA, LLC — Form D/A
AERIAL BIOPHARMA, LLC of MORRISVILLE, NC, a company, filed a Form D amendment with the SEC on 2013-10-09. The offering totals $12.0M, of which $9.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-09
- Form: D/A
- Accession: 0001532417-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $9.5M
- Remaining: $2.5M
- Investors: 31
- Date of first sale: 2011-10-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-167025
Issuer
- Name: AERIAL BIOPHARMA, LLC
- CIK: 0001532417
- Entity type: Limited Liability Company
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2011
- Address: 9001 AERIAL CENTER PARKWAY, SUITE 110, MORRISVILLE, NC, 27560
- Phone: 919-460-9500
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David J Adair | Director | Cary, NC |
| GARY BREAM | Director | MORRISVILLE, NC |
| STEPHEN BUTTS | Director | MORRISVILLE, NC |
| Moise Khayrallah | Director | Durham, NC |
| GARY BREAM | Executive Officer | MORRISVILLE, NC |
| STEPHEN BUTTS | Executive Officer | MORRISVILLE, NC |
| Moise Khayrallah | Executive Officer | Durham, NC |
Other filings by this issuer (2)
More